Cargando…

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study

Detalles Bibliográficos
Autores principales: Szerman, Nestor, Basurte-Villamor, Ignacio, Vega, Pablo, Martinez-Raga, Jose, Parro-Torres, Carlos, Cambra Almerge, Julia, Grau-López, Lara, De Matteis, Mario, Arias, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060974/
https://www.ncbi.nlm.nih.gov/pubmed/32112360
http://dx.doi.org/10.1007/s40801-020-00184-w
_version_ 1783504323840311296
author Szerman, Nestor
Basurte-Villamor, Ignacio
Vega, Pablo
Martinez-Raga, Jose
Parro-Torres, Carlos
Cambra Almerge, Julia
Grau-López, Lara
De Matteis, Mario
Arias, Francisco
author_facet Szerman, Nestor
Basurte-Villamor, Ignacio
Vega, Pablo
Martinez-Raga, Jose
Parro-Torres, Carlos
Cambra Almerge, Julia
Grau-López, Lara
De Matteis, Mario
Arias, Francisco
author_sort Szerman, Nestor
collection PubMed
description
format Online
Article
Text
id pubmed-7060974
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-70609742020-03-23 Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study Szerman, Nestor Basurte-Villamor, Ignacio Vega, Pablo Martinez-Raga, Jose Parro-Torres, Carlos Cambra Almerge, Julia Grau-López, Lara De Matteis, Mario Arias, Francisco Drugs Real World Outcomes Correction Springer International Publishing 2020-02-28 /pmc/articles/PMC7060974/ /pubmed/32112360 http://dx.doi.org/10.1007/s40801-020-00184-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Correction
Szerman, Nestor
Basurte-Villamor, Ignacio
Vega, Pablo
Martinez-Raga, Jose
Parro-Torres, Carlos
Cambra Almerge, Julia
Grau-López, Lara
De Matteis, Mario
Arias, Francisco
Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
title Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
title_full Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
title_fullStr Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
title_full_unstemmed Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
title_short Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
title_sort correction to: once‑monthly long‑acting injectable aripiprazole for the treatment of patients with schizophrenia and co‑occurring substance use disorders: a multicentre, observational study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060974/
https://www.ncbi.nlm.nih.gov/pubmed/32112360
http://dx.doi.org/10.1007/s40801-020-00184-w
work_keys_str_mv AT szermannestor correctiontooncemonthlylongactinginjectablearipiprazoleforthetreatmentofpatientswithschizophreniaandcooccurringsubstanceusedisordersamulticentreobservationalstudy
AT basurtevillamorignacio correctiontooncemonthlylongactinginjectablearipiprazoleforthetreatmentofpatientswithschizophreniaandcooccurringsubstanceusedisordersamulticentreobservationalstudy
AT vegapablo correctiontooncemonthlylongactinginjectablearipiprazoleforthetreatmentofpatientswithschizophreniaandcooccurringsubstanceusedisordersamulticentreobservationalstudy
AT martinezragajose correctiontooncemonthlylongactinginjectablearipiprazoleforthetreatmentofpatientswithschizophreniaandcooccurringsubstanceusedisordersamulticentreobservationalstudy
AT parrotorrescarlos correctiontooncemonthlylongactinginjectablearipiprazoleforthetreatmentofpatientswithschizophreniaandcooccurringsubstanceusedisordersamulticentreobservationalstudy
AT cambraalmergejulia correctiontooncemonthlylongactinginjectablearipiprazoleforthetreatmentofpatientswithschizophreniaandcooccurringsubstanceusedisordersamulticentreobservationalstudy
AT graulopezlara correctiontooncemonthlylongactinginjectablearipiprazoleforthetreatmentofpatientswithschizophreniaandcooccurringsubstanceusedisordersamulticentreobservationalstudy
AT dematteismario correctiontooncemonthlylongactinginjectablearipiprazoleforthetreatmentofpatientswithschizophreniaandcooccurringsubstanceusedisordersamulticentreobservationalstudy
AT ariasfrancisco correctiontooncemonthlylongactinginjectablearipiprazoleforthetreatmentofpatientswithschizophreniaandcooccurringsubstanceusedisordersamulticentreobservationalstudy